• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

COVID-19 Vulnerability Index Identifies Urban Populations at High Risk

by Jasmine Pennic 03/24/2020 Leave a Comment

COVID-19 Vulnerability Index Identifies Urban Populations at High Risk

What You Should Know:

– RS21 has developed the Urban Health Vulnerability Index (UHVI) to help local governments and health planners identify urban populations at high risk for COVID-19, including older adults and people with serious medical conditions, such as heart disease, diabetes, and lung disease.

– The UHVI tool uncovers which parts of our communities could be most affected by a COVID-19 outbreak and allows local governments to anticipate where resources may be needed the most.


Data science and visualization company RS21 has created a data analytics website to help address the challenges of COVID-19. The Urban Health Vulnerability Index (UHVI) identifies urban populations at high risk for COVID-19, including older adults and people with serious medical conditions. The public health app is intended to support mid- to long-term planning in the face of health, economic and social disruptions.

The UHVI quickly and clearly communicates information in a map-type interface, making it easy to use by decision-makers, analysts and citizens. Datasets come from the Centers for Disease Control, the US Census, COVID-19 cases, healthcare facilities and other disparate data sources.

Urban Health Vulnerability Index Coverage Areas

The UHVI originally included metro areas in New Mexico where the company is headquartered. It now shows data for the following cities:

Albuquerque, NM

Aurora, CO

Atlanta, GA

Chicago, IL

Colorado Springs, CO

Denver, CO

Las Cruces, NM

New Orleans, LA

New York, NY

Phoenix, AZ

Santa Fe, NM

Washington, D.C.

UHVI Methodology:

The UHVI measures the overall chronic disease burden of a census tract. Chronic conditions used calculate the UHVI include: asthma, COPD, diabetes, cancer, smoking, coronary heart disease, hypertension, stroke, kidney disease, and old age (>= 65 years). For each state we rank census tracts by the prevalence of each chronic condition. We then sum these condition ranks for each census tract to get an aggregate score. This aggregate score is then used to rank each tract within the state producing the final UHVI.

Tagged With: Asthma, cancer, COPD, Coronavirus (COVID-19), data analytics, diabetes, Heart, heart disease, Hypertension, lung, risk, WASHINGTON

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |